Published in AIDS Weekly, November 24th, 2003
Such assessment could be invaluable as antiretroviral drugs become available in less-developed countries where laboratory based CD4-cell count assessment is unrealistic, according to the Lancet-published research.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.